# Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity

> **NCT04902729** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 48 (actual)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT04902729
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-20
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04902729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04902729, "Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04902729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*